# Revena

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/revena

- Industry: Healthcare IT
- Headquarters: Sao Paulo, Brazil
- Website: www.revena.com.br
- Total disclosed funding: $8M
- Latest round: Seed (Jan 28, 2026)
- Investors on record: 3

## About

Based in Brazil, Revena provides advanced software solutions that streamline the medical billing process for healthcare institutions, enhancing operational efficiency and compliance within the healthcare sector. Founded in 2024 by Mateus Noronha and Diogo Freitas, Revena operates from São Paulo, Brazil, focusing on innovative software to facilitate medical billing. The current CEO is Mateus Noronha. In January 2026, Revena raised USD 8 million in seed funding led by Canary, with participation from Flourish Ventures and Caravela Capital. The company will use the funding to enhance its medical billing software and expand its hospital network. Revena specializes in an artificial intelligence (AI) platform designed to automate the medical billing process for healthcare institutions. Its offerings include the automated interpretation of contractual clauses, processing medical records, prescriptions, and clinical evolutions to ensure regulatory compliance and minimize errors. Revena's technology is crucial for hospitals, reducing manual labor within hospital information systems and expediting administrative processes, particularly for those managing complex billing scenarios. The company primarily serves hospitals in Brazil, especially in regions like São Paulo and Sergipe, focusing on enhancing operational efficiency and accuracy in medical billing.Revena generates revenue through partnerships with healthcare institutions, offering AI-enabled billing solutions on a subscription basis. Fees are dependent on the scale of implementation, which may vary based on user numbers or transaction volumes. This model enables hospitals to manage over 100 unique contracts with varying rules, ultimately minimizing the time spent on manual billing tasks and enhancing billing accuracy.In January 2026, Revena secured USD 8.000 mn in Seed funding, led by Canary with participation from Flourish Ventures and Caravela Capital. The funding will be utilized to enhance its medical billing software and expand its network of hospitals. The company plans to introduce new products aimed at improving efficiency and compliance in medical billing, while also targeting expansion into additional regions within Brazil to increase market penetration.

## Funding rounds

- Seed, Jan 28, 2026, $8M — Canary, Flourish Ventures, Caravela Capital

## Investors

- Canary (https://capitalatlas.ai/funds/canary) — Seed
- Flourish Ventures (https://capitalatlas.ai/funds/flourish-ventures) — Seed
- Caravela Capital (https://capitalatlas.ai/funds/caravela-capital) — Seed